(+)-pilocarpine affects expression EXP 6480464 Pilocarpine affects the expression of GAD2 protein CTD PMID:15857427 (+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of GAD2 mRNA, Pilocarpine results in increased expression of GAD2 protein CTD PMID:15987249 , PMID:16797850 (+)-pilocarpine decreases expression EXP 6480464 Pilocarpine results in decreased expression of GAD2 protein CTD PMID:12183020 (aminooxy)acetic acid decreases activity EXP 6480464 Aminooxyacetic Acid results in decreased activity of GAD2 protein CTD PMID:12634427 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of GAD2 mRNA CTD PMID:28555334 17alpha-ethynylestradiol affects expression ISO RGD:10616 6480464 Ethinyl Estradiol affects the expression of GAD2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:10616 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAD2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:10616 6480464 Ethinyl Estradiol results in increased expression of GAD2 mRNA CTD PMID:17942748 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 , PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10616 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAD2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GAD2 mRNA CTD PMID:32109520 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of GAD2 protein CTD PMID:26068050 3-mercaptopropanoic acid decreases activity EXP 6480464 3-Mercaptopropionic Acid results in decreased activity of GAD2 protein CTD PMID:4154755 3-mercaptopropanoic acid multiple interactions ISO RGD:733945 6480464 3-Mercaptopropionic Acid binds to and results in decreased activity of GAD2 protein CTD PMID:35151785 4,4'-sulfonyldiphenol increases expression ISO RGD:733945 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GAD2 mRNA CTD PMID:33476716 4,4'-sulfonyldiphenol decreases expression ISO RGD:10616 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GAD2 mRNA CTD PMID:30951980 4-aminopyridine multiple interactions EXP 6480464 KCNIP1 mRNA promotes the reaction [4-Aminopyridine results in increased expression of GAD2 mRNA] CTD PMID:25917026 4-aminopyridine increases expression EXP 6480464 4-Aminopyridine results in increased expression of GAD2 mRNA CTD PMID:25917026 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GAD2 mRNA CTD PMID:24780913 aflatoxin B1 increases expression ISO RGD:10616 6480464 Aflatoxin B1 results in increased expression of GAD2 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:10616 6480464 Tretinoin results in increased expression of GAD2 mRNA CTD PMID:11841568 amitraz affects expression EXP 6480464 amitraz affects the expression of GAD2 mRNA CTD PMID:26141220 amitraz multiple interactions EXP 6480464 [methylhistaprodifen co-treated with Idazoxan] inhibits the reaction [amitraz affects the expression of GAD2 mRNA] more ... CTD PMID:26141220 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GAD2 mRNA CTD PMID:16483693 Aroclor 1254 multiple interactions EXP 6480464 [aroclor 1242 co-treated with aroclor 1248 co-treated with Chlorodiphenyl (54% Chlorine) co-treated with aroclor 1260] results in decreased expression of GAD2 protein CTD PMID:17324953 arsane affects methylation ISO RGD:733945 6480464 Arsenic affects the methylation of GAD2 gene CTD PMID:25304211 arsane decreases expression ISO RGD:10616 6480464 Arsenic results in decreased expression of GAD2 mRNA CTD PMID:33124703 arsenic atom affects methylation ISO RGD:733945 6480464 Arsenic affects the methylation of GAD2 gene CTD PMID:25304211 arsenic atom decreases expression ISO RGD:10616 6480464 Arsenic results in decreased expression of GAD2 mRNA CTD PMID:33124703 arsenite(3-) increases methylation ISO RGD:733945 6480464 arsenite results in increased methylation of GAD2 promoter CTD PMID:23974009 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GAD2 mRNA CTD PMID:21839799 benzo[a]pyrene decreases methylation ISO RGD:733945 6480464 Benzo(a)pyrene results in decreased methylation of GAD2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:733945 6480464 Benzo(a)pyrene affects the methylation of GAD2 5' UTR CTD PMID:27901495 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of GAD2 mRNA CTD PMID:15620428 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GAD2 mRNA CTD PMID:26950200 bisphenol A decreases expression ISO RGD:10616 6480464 bisphenol A results in decreased expression of GAD2 mRNA CTD PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GAD2 mRNA CTD PMID:34947998 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of GAD2 mRNA CTD PMID:31129395 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GAD2 mRNA CTD PMID:22957036 , PMID:25181051 bisphenol F decreases expression ISO RGD:10616 6480464 bisphenol F results in decreased expression of GAD2 mRNA CTD PMID:30951980 bisphenol F decreases methylation ISO RGD:733945 6480464 bisphenol F results in decreased methylation of GAD2 gene CTD PMID:31601247 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of GAD2 protein CTD PMID:28903499 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of GAD2 mRNA CTD PMID:32479839 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of GAD2 protein CTD PMID:34058248 chlorpyrifos affects binding ISO RGD:733945 6480464 Chlorpyrifos binds to [GAD2 protein binds to Pyridoxal Phosphate], Chlorpyrifos binds to GAD2 protein CTD PMID:35151785 clozapine increases expression ISO RGD:10616 6480464 Clozapine results in increased expression of GAD2 mRNA CTD PMID:17266109 clozapine increases expression EXP 6480464 Clozapine results in increased expression of GAD2 mRNA CTD PMID:18923069 Cyclopamine decreases expression ISO RGD:10616 6480464 cyclopamine results in decreased expression of GAD2 mRNA CTD PMID:20865013 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of GAD2 protein CTD PMID:34189720 diazepam decreases expression EXP 6480464 Diazepam results in decreased expression of GAD2 mRNA CTD PMID:15802192 diazinon affects binding ISO RGD:733945 6480464 Diazinon binds to [GAD2 protein binds to Pyridoxal Phosphate], Diazinon binds to GAD2 protein CTD PMID:35151785 dichloroacetic acid decreases expression ISO RGD:10616 6480464 Dichloroacetic Acid results in decreased expression of GAD2 mRNA CTD PMID:28962523 diisopropyl fluorophosphate affects binding ISO RGD:733945 6480464 Isoflurophate binds to [GAD2 protein binds to Pyridoxal Phosphate], Isoflurophate binds to GAD2 protein CTD PMID:35151785 dioxygen decreases expression ISO RGD:10616 6480464 Oxygen deficiency results in decreased expression of GAD2 mRNA CTD PMID:29107683 dioxygen multiple interactions ISO RGD:10616 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Oxygen deficiency results in decreased expression of GAD2 protein], Oxygen deficiency results in decreased expression of and results in increased degradation of GAD2 protein CTD PMID:29107683 dorsomorphin multiple interactions ISO RGD:733945 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of GAD2 mRNA CTD PMID:31464424 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GAD2 protein CTD PMID:31464424 entinostat decreases expression ISO RGD:733945 6480464 entinostat results in decreased expression of GAD2 mRNA CTD PMID:27188386 ethanol affects splicing ISO RGD:10616 6480464 Ethanol affects the splicing of GAD2 mRNA CTD PMID:30319688 fenamidone decreases expression ISO RGD:10616 6480464 fenamidone results in decreased expression of GAD2 mRNA CTD PMID:27029645 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of GAD2 protein CTD PMID:19359144 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of GAD2 mRNA CTD PMID:9526047 gamma-aminobutyric acid increases chemical synthesis EXP 6480464 GAD2 protein results in increased chemical synthesis of gamma-Aminobutyric Acid CTD PMID:12634427 glyphosate affects binding ISO RGD:733945 6480464 glyphosate binds to [GAD2 protein binds to Pyridoxal Phosphate], glyphosate binds to GAD2 protein CTD PMID:35151785 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of GAD2 mRNA, Haloperidol results in decreased expression of GAD2 protein CTD PMID:18923069 , PMID:19359144 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of GAD2 mRNA CTD PMID:18923069 hydrazine decreases activity EXP 6480464 hydrazine results in decreased activity of GAD2 protein CTD PMID:12634427 idazoxan multiple interactions EXP 6480464 [methylhistaprodifen co-treated with Idazoxan] inhibits the reaction [amitraz affects the expression of GAD2 mRNA], Idazoxan inhibits the reaction [amitraz affects the expression of GAD2 mRNA] CTD PMID:26141220 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of GAD2 mRNA CTD PMID:16797850 L-glutamic acid multiple interactions ISO RGD:733945 6480464 [GAD2 protein binds to Pyridoxal Phosphate] which binds to and results in increased metabolism of Glutamic Acid CTD PMID:35151785 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of GAD2 protein CTD PMID:31785328 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of GAD2 protein CTD PMID:31785328 malathion affects binding ISO RGD:733945 6480464 Malathion binds to [GAD2 protein binds to Pyridoxal Phosphate], Malathion binds to GAD2 protein CTD PMID:35151785 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GAD2 mRNA CTD PMID:15601951 methylmercury chloride decreases expression ISO RGD:10616 6480464 methylmercuric chloride results in decreased expression of GAD2 mRNA CTD PMID:21385734 Mipafox affects binding ISO RGD:733945 6480464 mipafox binds to [GAD2 protein binds to Pyridoxal Phosphate], mipafox binds to GAD2 protein CTD PMID:35151785 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of GAD2 mRNA CTD PMID:19733649 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of GAD2 protein CTD PMID:19733649 monosodium L-glutamate affects expression EXP 6480464 Sodium Glutamate affects the expression of GAD2 protein CTD PMID:19733649 morphine increases expression ISO RGD:10616 6480464 Morphine results in increased expression of GAD2 mRNA CTD PMID:21178816 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:10616 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Oxygen deficiency results in decreased expression of GAD2 protein] CTD PMID:29107683 N-ethylmaleimide decreases activity ISO RGD:733945 6480464 Ethylmaleimide results in decreased activity of GAD2 protein CTD PMID:15836621 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of GAD2 mRNA CTD PMID:28555334 Nonylphenol decreases expression EXP 6480464 nonylphenol results in decreased expression of GAD2 mRNA CTD PMID:15620428 olanzapine decreases expression EXP 6480464 olanzapine results in decreased expression of GAD2 protein CTD PMID:19359144 oxidopamine multiple interactions EXP 6480464 Levodopa promotes the reaction [Oxidopamine results in increased expression of GAD2 mRNA] CTD PMID:19660528 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of GAD2 mRNA CTD PMID:19660528 panobinostat multiple interactions ISO RGD:733945 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAD2 mRNA CTD PMID:27188386 paraoxon affects binding ISO RGD:733945 6480464 Paraoxon binds to [GAD2 protein binds to Pyridoxal Phosphate], Paraoxon binds to GAD2 protein CTD PMID:35151785 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of GAD2 mRNA, Paraquat results in decreased expression of GAD2 protein CTD PMID:18198484 , PMID:24521700 pentetrazol increases response to substance ISO RGD:10616 6480464 GAD2 gene mutant form results in increased susceptibility to Pentylenetetrazole CTD PMID:8954991 phencyclidine increases expression ISO RGD:10616 6480464 Phencyclidine results in increased expression of GAD2 mRNA CTD PMID:17266109 phenylmercury acetate decreases expression ISO RGD:733945 6480464 Phenylmercuric Acetate results in decreased expression of GAD2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:733945 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAD2 mRNA CTD PMID:27188386 picrotoxin increases expression EXP 6480464 Picrotoxin results in increased expression of GAD2 mRNA, Picrotoxin results in increased expression of GAD2 protein CTD PMID:15170462 , PMID:15382257 picrotoxin increases response to substance ISO RGD:10616 6480464 GAD2 gene mutant form results in increased susceptibility to Picrotoxin CTD PMID:8954991 pyridoxal 5'-phosphate affects binding ISO RGD:733945 6480464 Chlorpyrifos binds to [GAD2 protein binds to Pyridoxal Phosphate] more ... CTD PMID:15686475 more ... pyridoxal 5'-phosphate multiple interactions ISO RGD:733945 6480464 [GAD2 protein binds to Pyridoxal Phosphate] which binds to and results in increased metabolism of Glutamic Acid CTD PMID:35151785 sarin affects binding ISO RGD:733945 6480464 Sarin binds to [GAD2 protein binds to Pyridoxal Phosphate], Sarin binds to GAD2 protein CTD PMID:35151785 SB 431542 multiple interactions ISO RGD:733945 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sevoflurane increases expression ISO RGD:10616 6480464 Sevoflurane results in increased expression of GAD2 mRNA, Sevoflurane results in increased expression of GAD2 protein CTD PMID:30502404 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GAD2 mRNA CTD PMID:20376865 sodium arsenite decreases expression ISO RGD:10616 6480464 sodium arsenite results in decreased expression of GAD2 mRNA CTD PMID:36209798 Soman affects binding ISO RGD:733945 6480464 Soman binds to [GAD2 protein binds to Pyridoxal Phosphate], Soman binds to GAD2 protein CTD PMID:35151785 tamoxifen increases expression ISO RGD:10616 6480464 Tamoxifen results in increased expression of GAD2 mRNA CTD PMID:25123088 tamoxifen affects expression ISO RGD:10616 6480464 Tamoxifen affects the expression of GAD2 mRNA CTD PMID:17555576 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of GAD2 mRNA CTD PMID:31129395 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of GAD2 mRNA CTD PMID:33078273 triptonide increases expression ISO RGD:10616 6480464 triptonide results in increased expression of GAD2 mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:10616 6480464 Valproic Acid affects the expression of GAD2 mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:733945 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GAD2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:733945 6480464 Valproic Acid results in decreased expression of GAD2 mRNA CTD PMID:23179753 more ... valproic acid decreases expression ISO RGD:10616 6480464 Valproic Acid results in decreased expression of GAD2 mRNA CTD PMID:24896083 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GAD2 mRNA CTD PMID:19359144 venlafaxine hydrochloride decreases expression EXP 6480464 Venlafaxine Hydrochloride results in decreased expression of GAD2 mRNA CTD PMID:25423262 VX nerve agent affects binding ISO RGD:733945 6480464 VX binds to [GAD2 protein binds to Pyridoxal Phosphate], VX binds to GAD2 protein CTD PMID:35151785
